Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jun 26, 2020
Date Accepted: Sep 6, 2020
Date Submitted to PubMed: Oct 15, 2020

The final, peer-reviewed published version of this preprint can be found here:

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach

Khan JY, Khondaker MTI, Hoque IT, Al-Absi HR, Rahman MS, Guler R, Alam T, Rahman MS

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach

JMIR Med Inform 2020;8(11):e21648

DOI: 10.2196/21648

PMID: 33055059

PMCID: 7674141

Towards Preparing a Knowledgebase to Explore Potential Drugs and Biomedical Entities Related to COVID-19

  • Junaed Younus Khan; 
  • Md. Tawkat Islam Khondaker; 
  • Iram Tazim Hoque; 
  • Hamada R Al-Absi; 
  • Mohammad Saifur Rahman; 
  • Reto Guler; 
  • Tanvir Alam; 
  • M. Sohel Rahman

ABSTRACT

Background:

Novel coronavirus disease 2019 (COVID-19) is taking a huge toll on public health. Along with the non-therapeutic preventive measurements, scientific efforts are currently focused, mainly, on the development of vaccines and pharmacological treatment with existing drugs. Summarizing evidences from scientific literatures on the discovery of treatment plan of COVID-19 under a platform would help the scientific community to explore the opportunities in a systematic fashion.

Objective:

The aim of this study is to explore the potential drugs and biomedical entities related to coronavirus related diseases, including COVID-19, that are mentioned on scientific literature through an automated computational approach.

Methods:

We mined the information from publicly available scientific literature and related public resources. Six topic-specific dictionaries, including human genes, human miRNAs, diseases, Protein Databank, drugs, and drug side effects, were integrated to mine all scientific evidence related to COVID-19. We employed an automated literature mining and labeling system through a novel approach to measure the effectiveness of drugs against diseases based on natural language processing, sentiment analysis, and deep learning. We also applied the concept of cosine similarity to confidently infer the associations between diseases and genes.

Results:

Based on the literature mining, we identified 1805 diseases, 2454 drugs, 1910 genes that are related to coronavirus related diseases including COVID-19. Integrating the extracted information, we developed the first knowledgebase platform dedicated to COVID-19, which highlights potential list of drugs and related biomedical entities. For COVID-19, we have highlighted multiple case studies on existing drugs along with a confidence score for their applicability in the treatment plan. The resulting knowledgebase is made available as an open source tool, named COVID-19Base, for the scientific community: http://77.68.43.135:97/search/.

Conclusions:

Proper investigation of the mined biomedical entities along with the identified interactions among those would help the research community to discover possible ways for the therapeutic treatment of COVID-19.


 Citation

Please cite as:

Khan JY, Khondaker MTI, Hoque IT, Al-Absi HR, Rahman MS, Guler R, Alam T, Rahman MS

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach

JMIR Med Inform 2020;8(11):e21648

DOI: 10.2196/21648

PMID: 33055059

PMCID: 7674141

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.